2 hours agoBusiness
28LENS
2 SourcesGujarat, India
thebalanced.newsSpeciality Medicines to List Shares on BSE SME Platform Following Rs 29 Crore IPO
Speciality Medicines, a speciality pharmaceuticals company with a global presence, is set to debut its shares on the BSE SME platform. The IPO, a fresh issue aiming to raise approximately Rs 29 crore, was priced between Rs 117 and Rs 124 per share. Proceeds will support research and development, international registrations, and marketing. The company operates through contract manufacturing and distribution across over 35 countries and 20 Indian states. Market maker and lead manager roles are assigned to Aikyam Capital and Unistone Capital, respectively.
Political Bias
0%100%0%
Sentiment
58%
20 stories available
View AI Analysis
Bias Analysis: The articles focus on financial and corporate information without political framing. Coverage centers on the company's IPO details, business model, and market presence, reflecting a neutral business perspective. There is no evident political viewpoint or partisan framing in the sources.
Sentiment: The tone across the articles is neutral and informational, providing factual details about the IPO and company operations without positive or negative bias. The content aims to inform investors and readers about the listing and related financial data without emotive language.
Lens Score: 28/100 — Story is well-covered by media outlets. Public interest: 0/100. Coverage gap: 100%.
Related Coverage
Select a news story to see related coverage from other media outlets.